First-trimester prediction of early-onset preeclampsia using PAPP-A and mean arterial pressure
Biomolecules and Biomedicine · 23.07.2025 · 25 (12) · 2801-2809
DOI: 10.17305/bb.2025.12814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 23.07.2025. Verfasst von Fatma Beyazıt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Çanakkale Onsekiz Mart University, Medical School, Department of Obstetrics and Gynecology, Çanakkale, Turkey. Hauptthemen laut MEDLINE: Pregnancy-Associated Plasma Protein-A, Pre-Eclampsia, Pregnancy Trimester, First, Arterial Pressure. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Predicting early-onset preeclampsia (EOP) during the initial stages of pregnancy is essential for effective clinical management and enhancing maternal-fetal outcomes. Current methodologies, which include clinical and demographic risk factors, biophysical parameters, and serum biomarkers, exhibit limited efficacy in predicting EOP. This study aimed to evaluate whether the incorporation of pregnancy-associated plasma protein-A (PAPP-A) and mean arterial pressure (MAP) significantly enhances EOP detection. We conducted a retrospective case-control study involving 518 gravidas, of whom 202 developed EOP and 316 experienced normal pregnancies. Logistic regression models were employed to assess EOP predictions, and the predictive accuracy of these statistical models was evaluated using receiver-operating characteristic curve analysis. Our findings indicate that lower PAPP-A levels, higher MAP, and increased body mass index (BMI) are associated with EOP. Notably, in pregnant women between 11+0 and 13+6 weeks of gestation, a 1-point decrease in PAPP-A corresponds to an 84% increase in the likelihood of developing EOP. The predictive performance of PAPP-A improves significantly when combined with other factors such as BMI, MAP, and a history of diabetes mellitus (DM). The risk of EOP is substantially heightened (20.410 times, 95% CI: 11.104-37.515) in patients exhibiting low PAPP-A levels (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Çanakkale Onsekiz Mart University, Medical School, Department of Obstetrics and Gynecology, Çanakkale, Turkey.
- Çanakkale Onsekiz Mart University, Medical School, Department of Emergency Medicine, Çanakkale, Turkey.
- Ezine State Hospital, Obstetrics and Gynecology Clinic, Çanakkale, Turkey.
- Çanakkale Onsekiz Mart University, Medical School, Department of Medical Biochemistry, Çanakkale, Turkey.
- Çanakkale Onsekiz Mart University, Medical School, Department of Anesthesiology, Çanakkale, Turkey.
- Ipsala State Hospital, Obstetrics and Gynecology Clinic, Edirne, Turkey.
Zitieren
APA
Beyazıt, F., Pek, E., Daş, M., Duran, M. N., Ülker Çakır, D., Şen, B. N., Kiraz, H. A., Koçyiğit Yılmaz, D., & Ünal Çetin, E. (2025). First-trimester prediction of early-onset preeclampsia using PAPP-A and mean arterial pressure. Biomolecules and Biomedicine, 25(12), 2801-2809. https://doi.org/10.17305/bb.2025.12814
Vancouver
Beyazıt F, Pek E, Daş M, Duran MN, Ülker Çakır D, Şen BN, et al. First-trimester prediction of early-onset preeclampsia using PAPP-A and mean arterial pressure. Biomolecules and Biomedicine. 2025;25(12):2801-2809. doi:10.17305/bb.2025.12814
BibTeX
@article{Beyazt2025,
author = {Beyazıt, Fatma and Pek, Eren and Daş, Murat and Duran, Mehmet Nuri and Ülker Çakır, Dilek and Şen, Başak Nil and Kiraz, Hasan Ali and Koçyiğit Yılmaz, Deniz and Ünal Çetin, Ece},
title = {First-trimester prediction of early-onset preeclampsia using PAPP-A and mean arterial pressure},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {25},
number = {12},
pages = {2801--2809},
doi = {10.17305/bb.2025.12814}
}
EUVIMED